About CGI Pharmaceuticals
CGI Pharmaceuticals is a Healthcare company based in Branford (United States) founded in 2000, and was acquired by Gilead in June 2010. Small molecule therapeutics are developed for oncology and immunology indications. CGI Pharmaceuticals has raised $44.3 million across 2 funding rounds from investors including Gilead, Flagship Pioneering and Lilly Ventures. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is CGI Pharmaceuticals, Inc. Its competitors include Moderna, BeiGene and Incyte; 2 of its 3 listed competitors have raised funding.
Company details
CGI Pharmaceuticals, a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocytemacrophage, and B-cell functions.in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as ASKA (Analog Sensitive Kinase Alleles) to understand kinase function.
- Headquarters Branford, United States
- Stage Acquired
- SectorsHealthcare
- Website cgipharma.com
- Social LinkedIn
- Acquired by Gilead (Jun 2010)
- Legal Name Cgi Pharmaceuticals, Inc.
Funding Insights of CGI Pharmaceuticals
CGI Pharmaceuticals has successfully raised a total of $44.3M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $22.3 million completed in January 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.3M
- Total Rounds 2
- Last Round Series C — $22.3M
- First Round $22M
(Jan 2001)
- Investors Count 6
All 2 funding rounds of CGI Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2004 | $22.3M | Series C | – | Lilly Ventures | |
| Jan 2001 | $22M | Series B | – | – | – |
7 investors in total: 7 institutional.
Investors in CGI Pharmaceuticals
CGI Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Flagship Pioneering and Lilly Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage life sciences investments are targeted in the healthcare sector. | lillyventures.com | Indianapolis, United States | ||
Capital is provided to support biomedical industry innovations. | 2000 | etpvc.com | South San Francisco, USA | |
Venture capital services for biotech, IT, and innovative sectors in Connecticut. | ctinnovations.com | |||
Life sciences-focused venture capital firm | 1999 | flagshippioneering.com | Cambridge, United States | |
| vectorfund.com | ||||
Invests in biotech firms developing life-saving drugs and technologies. | mpmcapital.com | |||
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | gilead.com | Foster City, United States |
Investor details for CGI Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CGI Pharmaceuticals
4 dated milestones of CGI Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.
- Founded CGI Pharmaceuticals is founded.
- Funding First funding round of $22.0M.
- Funding Latest funding round, Series C, of $22.3M.
- Exit Acquired by Gilead.
Competitors of CGI Pharmaceuticals
CGI Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Moderna, BeiGene and Incyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. |
Detailed competitors of CGI Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as CGI Pharmaceuticals (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CGI Pharmaceuticals
CGI Pharmaceuticals was founded in 2000 and raised its 1st funding round 1 year after it was founded.
CGI Pharmaceuticals is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
CGI Pharmaceuticals is a funded company, having raised a total of $44.3M across 2 funding rounds to date. The company's 1st funding round was a Series B of $22M, raised on Jan 2001.
CGI Pharmaceuticals, a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocytemacrophage, and B-cell functions.in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as ASKA (Analog Sensitive Kinase Alleles) to understand kinase function.
CGI Pharmaceuticals has 7 investors. Key investors include Gilead, Flagship Pioneering, Lilly Ventures, ETP Capital, and Connecticut Innovations.
CGI Pharmaceuticals operates through Cgi Pharmaceuticals, Inc..
Yes. CGI Pharmaceuticals was acquired by Gilead in June 2010.